- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03568149
Pelvic Congestion Syndrome and Endometriosis (VES)
Ultrasound Evaluation of the Prevalence of Pelvic Congestion Syndrome in Patients With Endometriosis
The pelvic congestion syndrome (PCS) is a complex and multifactorial condition associated with inflammatory and hormonal etiophatogenesis similar to the endometriosis.
Furthermore, both pathologies share same clinical symptoms as chronic pelvic pain and dyspareunia.
Our hypothesis is that PCS prevalence is higher in patients with endometriosis than in those without clinical or ultrasound signs of endometriosis.
Study Overview
Status
Conditions
Detailed Description
Patients undergoing routine gynecological examinations are included in the study.
Patients are divided into 2 groups:
- Group A: with endometriosis
- Group B: without clinical or ultrasound signs of endometriosis This is an observational, monocentric, prospective, exploratory study. The aim is to assess PCS incidence, associated symptoms and ultrasound characteristics in patients with endometriosis and to compare those findings to those of patients who do not present clinical or ultrasound signs of endometriosis.
The study also evaluates the correlation between:
- Type of pain symptoms (dysmenorrhea, chronic pelvic pain, ovulation pain, dyspareunia, dysuria, dyschezia) and PCS
- Pain severity (assessed according to VAS scale from 0= no pain to 10= unbearable pain) and PCS
- Symptoms and ongoing medical treatments
- History of pelvic surgery and PCS.
Ultrasound parameters of pelvic vascular insufficiency are:
- Ovarian vein diameter <4mm
- Slow ovarian blood flow (<3cm/sec)
- Retrograde blood flow
- Dilated arcuate veins communicating with pelvic varices
- The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious
This evaluation includes the study of uterine and ovarian vessels, using different techniques:
- Standard 2D study: it allows to measure vessels diameter
- Vascular doppler study: it allows to evaluate flow direction and blood speed
- 3D color study: it allows a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.
- Ultrasound images are evaluated independently by two operators.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Diego Raimondo
- Phone Number: 00390512144385
- Email: die.raimondo@gmail.com
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40138
- Recruiting
- Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital
-
Contact:
- Diego Raimondo
- Phone Number: 00390512144385
- Email: die.raimondo@gmail.com
-
Principal Investigator:
- Mohamed Mabrouk
-
Principal Investigator:
- Renato Seracchioli
-
Principal Investigator:
- Diego Raimondo
-
Sub-Investigator:
- Simona Del Forno
-
Sub-Investigator:
- Raffaella Iodice
-
Sub-Investigator:
- Manuela Mastronardi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria (Group A):
- Obtaining Informed Consent
- Nulliparity
- Clinical or ultrasounds signs of endometriosis
Inclusion Criteria (Group B):
- Obtaining Informed Consent
- Nulliparity
Exclusion Criteria:
- Menopause
- Actual or previous pregnancy
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group A: endometriosis
assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.
|
First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds).
Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected.
The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.
Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters:
This evaluation includes the study of uterine and ovarian vessels, using different techniques:
|
Group B: no endometriosis
assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.
|
First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds).
Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected.
The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.
Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters:
This evaluation includes the study of uterine and ovarian vessels, using different techniques:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of pelvic congestive syndrome in patients with endometriosis
Time Frame: 1 day, first medical examination
|
Comparison of pelvic congestive syndrome symptoms and ultrasounds characteristics, assessed by standard gynecological examination (bimanual gynecological examination and gynecological ultrasounds), between patients with endometriosis (Group A) and without clinical or ultrasound signs of endometriosis.
|
1 day, first medical examination
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between type of pain and pelvic congestive syndrome
Time Frame: 1 day, first medical examination
|
Evaluation of the type of pain (dysmenorrhea, chronic pelvic pain, ovulation pain, dyspareunia, dysuria, dyschezia) presented by patients with pelvic congestive syndrome.
|
1 day, first medical examination
|
Correlation between pain severity and pelvic congestive syndrome
Time Frame: 1 day, first medical examination
|
Evaluation of a possible correlation between pain severity and the presence of pelvic congestive syndrome.
Pain severity is assessed according to Visual Analogue Scale (VAS scale from 0= no pain to 10= unbearable pain).
|
1 day, first medical examination
|
Correlation between symptoms and ongoing medical treatments
Time Frame: 1 day, first medical examination
|
Evaluation of a possible correlation between symptoms and ongoing medical treatments in patients with pelvic congestive syndrome
|
1 day, first medical examination
|
Correlation between history of pelvic surgery and pelvic congestive syndrome
Time Frame: 1 day, first medical examination
|
Evaluation of a possible correlation between history of pelvic surgery and the presence of pelvic congestive syndrome
|
1 day, first medical examination
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VES Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
Clinical Trials on assessment of pain symptoms at first medical examination
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknown
-
University Hospital, MontpellierRecruitingTemporomandibular Joint DisordersFrance
-
Ohio State University Comprehensive Cancer CenterCompletedTongue Cancer | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous Carcinoma | Stage 0 Lip and Oral Cavity CancerUnited States
-
Freeman-Sheldon Research Group, Inc.TerminatedDepressive Disorder | Craniofacial Abnormalities | Posttraumatic Stress Disorder | ArthrogryposisUnited States, Guatemala
-
Freeman-Sheldon Research Group, Inc.WithdrawnCraniofacial Abnormalities | ArthrogryposisUnited States
-
University Hospital, Basel, SwitzerlandRecruitingTriage Risk StratificationSwitzerland
-
Centre Hospitalier Universitaire, AmiensCompletedElderly | Knowledge, Attitudes, PracticeFrance
-
Poitiers University HospitalCompleted
-
National Medical Research Center for Children's...RecruitingAortic Valve InsufficiencyRussian Federation
-
University Hospital, Basel, SwitzerlandCompletedTriage Risk StratificationSwitzerland